Details for 2020832900

Up to date per 03.04.2026

Actions

Title / Product Name

TRIPLE-AGONISTEN MIT AKTIVITÄT IN BEZUG AUF ALLE GLUCAGON-, GLP-1- UND GIP-REZEPTOREN ODER ZUR BEHANDLUNG VON LEBERERKRANKUNG

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2020832900

EP Publication Number

3936142

E-Number

1650122

Language

PCT Number

KR20008479

Publication Date

12.01.2022 A

17.01.2024 B1

Registration Date

17.01.2024

AT Publication Date

15.02.2024

Application Date

29.06.2020

Registration Number

Priorities

28.06.2019

20190077776

13.01.2020

20200004386

13.01.2020

20200004379

08.06.2020

20200069219

IPC

A61K 38/17 20060101AFI20230724BHEP

Maximum Duration of Protection

29.06.2040

Owner

Hanmi Pharm. Co., Ltd.214 Muha-ro Paltan-myeon Hwaseong-si, Gyeonggi-do 18536KR

Representative

Authorized Recipients

Paul CosmoviciGumpendorfer Straße 1421060 WienAT

Inventor

KWON, Hyun Joo550, Dongtangiheung-ro Hwaseong-si, Gyeonggi-do 18469KR

KIM, Jung Kuk550, Dongtangiheung-ro Hwaseong-si, Gyeonggi-do 18469KR

PARK, Eun Jin550, Dongtangiheung-ro Hwaseong-si, Gyeonggi-do 18469KR

LEE, Jong Min550, Dongtangiheung-ro Hwaseong-si, Gyeonggi-do 18469KR

LEE, Jong Suk550, Dongtangiheung-ro Hwaseong-si, Gyeonggi-do 18469KR

JO, Hyo Sang550, Dongtangiheung-ro Hwaseong-si, Gyeonggi-do 18469KR

CHOI, In Young550, Dongtangiheung-ro Hwaseong-si, Gyeonggi-do 18469KR

Information about Fees